Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ: ILMN )

136.22 +1.46 (+1.08%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,363,471
Open 134.70
Bid (Size) 133.00 (2)
Ask (Size) 137.50 (4)
Prev. Close 134.76
Today's Range 133.93 - 137.34
52wk Range 97.36 - 156.66
Shares Outstanding 158,600,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies
Cathie Wood-led Ark Invest made significant trades involving ACCD, DE, NTLA, PATH, CCJ, OKLO, ILMN, ESLT, and ABSI. 
Via Benzinga
Topics Government
Exposures Political
Illumina Raises Q4 Revenue Outlook To $1.10 Billion, Exceeding Street Expectations; Sees Solid Margins
Illumina raises Q4 and FY24 revenue outlook, expects solid margins, with projected 2024 EPS between $4.12 and $4.14. 
Via Benzinga

Performance

YTD
+4.04%
+4.04%
1 Month
+0.93%
+0.93%
3 Month
-4.04%
-4.04%
6 Month
+13.11%
+13.11%
1 Year
-1.91%
-1.91%

More News

Read More
Nvidia Eyes $1 Billion In Healthcare AI Revenue: Is This The Next Growth Frontier?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce
Via Benzinga
Topics Workforce
Exposures Layoff
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
Via Benzinga
How Is The Market Feeling About Illumina?
Via Benzinga
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
Via Benzinga
CD Genomics Unveils Advanced Mitochondrial DNA Sequencing to Deepen Insights into Genetic Research
Via Press Release Distribution Service
Santa Claus Rally: 10 S&P 500 Stocks That Consistently Outperform During Year-End Optimism
Via Benzinga
Topics Stocks
Exposures US Equities
Traders Fight The Grinch To Save The Santa Rally: 10 S&P 500 Stocks Poised For A Year-End Surge
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Super Micro Drops Below 50-Day Average, Faces Nasdaq 100 Removal Just Months After Entry
Via Benzinga
CD Genomics Enhances Whole Genome SNP Genotyping Services to Propel Genomic Discoveries
Via Press Release Distribution Service
Looking Into Illumina's Recent Short Interest
Via Benzinga
Nasdaq 100 Shakeup: 3 Stocks That Can Gain
Via Talk Markets
Topics Stocks / Equities
What's Going On With Illumina Stock On Monday?
Via Benzinga
What's Going On With Super Micro Computer Shares Monday?
Via Benzinga
US Stocks To Open Higher Ahead Of Fed's Decision This Week: Analyst Says 'Santa Comes Later In December'
Via Benzinga
Topics Economy
Exposures Interest Rates
Palantir Stock Is Joining the Nasdaq-100 Index, and Super Micro Computer Is Being Booted: What Investors Should Know
Via The Motley Fool
GRAIL: Biotech Stock Targeting $100B Cancer Market
Via MarketBeat
Topics Death
Exposures Death
MicroStrategy, Palantir, Axon Added To Nasdaq 100: Super Micro Computer, Moderna, Illumina Exit The Index
Via Benzinga
This D.R. Horton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
From Myriad Genetics, Inc.
Via GlobeNewswire
Smaller Cap Biotechs Are In Season: How Are We Doing?
Via Talk Markets
Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?
Via Benzinga
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.